Read Bill Heisel’s column, “Journalists Bag a Big One: The American Pain Foundation.” Excerpt:
The American Pain Foundation – an industry funded promoter of painkillers masquerading as a patient advocacy organization – closed its doors last week after it became the target of a U.S. Senate panel inquiry.
The action by the U.S. Senate Finance Committee and the surprisingly quick collapse of the foundation were prompted by two journalistic investigations.
Also see Carl Elliott’s column, “Making a Name for Yourself in the Ethics Business.” Excerpt:
Let’s start with a quiz. Can you tell which of these awards is real?
A) The Exxon Valdez Prize in Environmental Ethics
B) The Goldman Sachs Endowment in Business Ethics
C) The Richard Milhous Nixon Award for Ethics in Government
D) The Pfizer Fellowship in Bioethics
If you guessed D), you win. Yes, it is true that Pfizer has a rap sheet filled with felonies; yes, the company exploited Nigerian children in one of the deadliest research scandals in recent memory; and yes, in 2009 it paid out the (then) largest criminal fine in American history. But what better way to atone for past wrongdoing than a generous cash award to a bioethicist? The Pfizer Fellowship in Bioethics is a $100,000 grant that allows “researchers to explore ethical issues that arise in the everyday practice of contemporary medicine,” such as “conflicts of interest.”
Elliott will soon be participating in one of Adriane Fugh-Berman’s PharmedOut.org events at Georgetown, “Missing the Target: When Practitioners Harm More Than Heal.”
And Ed Silverman on Pharmalot.com recently wrote about “China, Bioethics and the Wild West.” Excerpt:
Next fall, the University of Pennsylvania will host a 10-day crash course in Bioethics in China, which some may argue is an oxymoron.
…
Pharmalot: You mentioned that the program receives industry grants. Some might say that’s an unnecessary influence.
Joe Powers, the executive director at UPenn’s Center for Neuroscience & Society, who previously held various jobs with different large drugmakers and is overseeing this effort: “Yes, we received grants from Merck and Sanofi to develop a bioethics program in China We started a consortium Each company is contributing seed money to establish a program and the University of Pennsylvania has committed funding, along with a large medical school in China I have no problem accepting industry funds… We have a conflict of interest steering committee here at Penn to make sure everything is ethical.”
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Comments are closed.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like